Active Ingredient(s):Dacarbazine, DTIC FDA Approved: * May 27, 1975 Pharm Company: *BAYER PHARMS Category:Cancer
Dacarbazine (DTIC), also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. For Hodgkin's it is often used together with vinblastine, bleomycin, and doxorubicin. It is given by injection into a vein.
Common side effects include loss of appetite, vomiting, low white blood cell count, and low platelets. Other serious side effects incl...
* May have multiple approval dates, manufacturers, or labelers.